Annual Spotlight on Early Career Investigators: A Cancer Research Mini-Symposium
The Spotlight on Early Career Investigators is an annual symposium highlighting the work of undergraduate students, pre- and post-doctoral scholars, research staff and residents/fellows in cancer research. Through this event, early career investigators meet experienced investigators, learn about potential research opportunities early in their career, and gain valuable career insights through presentations and networking.
Each year, a select group of investigators are accepted as symposium presenters with others offering poster presentations. Criteria used to judge the applications include scientific innovation, significance, and ultimate potential for clinical impact.
15th Annual Spotlight on Early Career Investigators: A Cancer Research Mini-Symposium
April 29, 2021
A virtual Event
Abstracts of all oral and poster presentations are available here
Laura Fejerman, M.Sc., Ph.D., Steps & Jumps: On How I Built a Career in Cancer Health Disparities Research
| 1:30 - 1:45 p.m. | Diedre Reitz, Lynch Syndrome: The known and unknown consequences of msh2 and msh6 deficiency |
| 1:45 - 2:00 p.m. |
Alan Lombard, Resistance to Olaparib is Dependent on Re-Emergence from G2/M Arrested Senescence |
| 2:00 - 2:15 p.m. |
Brent Weyers, Intraoperative Fluorescence Lifetime Imaging (FLIm) for Tumor Delineation and Surgical Guidance of Oral Cavity and Oropharyngeal Cancer |
| 2:15 - 2:25 p.m. |
Maria Munoz, Janai Carr-Ascher. Developing a Pre-Clinical Model of Metastatic Soft-Tissue Sarcoma |
| 2:30 - 2:45 p.m. |
Sylvia Cruz, Natural Killer and Cytotoxic T Cell Immune Infiltrates are Associated with Superior Outcomes in Soft Tissue Sarcomas |
| 2:45 - 3:00 p.m. | Estelle Yoo, MTAP deficiency reshapes the immune microenvironment and contributes to tumor evasion |
| 3:00 - 3:15 p.m. | Nathanial Stevens, Site-specific metabolic effects of acute naphthalene exposure in mice revealed by metabolomics of microdissected lung tissue |
| 1. | Mythili Ramachandran, Z. Ma, Y. Li. Novel Autophagy Inhibitor for the Treatment of Pancreatic Cancer |
| 2. | Samya Faiq, Roberto N Solis, Harveen Kaur Sekhon, Marianne Abouyared, Arnaud F Bewley, D. Greg Farwell, Andrew C Birkeland. Evaluating Number of Pathologic Lymph Nodes in Oral Cavity Cancer |
| 3. | Harveen Sekhon, Roberto N Solis, Samya Faiq, Marianne Abouyared, Arnaud F Bewley, D. Greg Farwell, Andrew C Birkeland. Bereavement Practices Amongst Head and Neck Oncologic Surgeons |
| 4. | Yatian Yang, Junjian Wang, Hongye Zou, Christopher P. Evans, Hong-Wu Chen. Chromatin Architecture Organizer BORIS Mediates ROR-γ Reprogramming of Chromatin Landscape in Advanced Prostate Cancer |
| 5. | Gabriella Tzuwei Lai, Yuh-Ru Julie Lee, Volkmar Heinrich, Su Hao Lo, Soichiro Yamada. Deciphering Force-dependent Interactions of Keratin and Cten Using in vitro Microneedle Stretch |
| 6. | Ryan Toedebusch, LA Wittenburg, ET Debebe, CA Lucchesi, and CM Toedebusch. Olfactomedin-like 3 PromotesPprotumorogenic Glioma-associated Microglia |
| 7. | Hongye Zou, Yatian Yang, Hong-Wu Chen. Induction of Chromatin Structural Change is a Key Determinant of Anti-tumor Potency of the Nuclear Receptor RORγ Antagonists |
| 8. | Julianne J. P. Cooley, Cyllene R. Morris, Arti Parikh-Patel, Vanessa A. Kennedy, Theresa H. M. Keegan. Cervical Cancer Incidence and Stage at Diagnosis Among Seniors ≥ 65 years in California |
| 9. | Xiong Zhang, Yang Yang and Hong-wu Chen. Nuclear Receptor ROR-γ and BRD4/BET Bromodomain Antagonists Synergistically Inhibits Neuroendocrine Differentiation in Prostate Cancer |
| 10. | Aman Arora, Neil Pugasehtti, Christopher P Evans, Marc A Dall’Era. Performance of High-Resolution Micro-Ultrasound for Diagnosing Clinically Significant Prostate Cancer in Men Undergoing a Screening MRI |
| 11. | Wei Zhu, Chun-mei Li, Rui-feng Wang, Gerardo G. Mackenzie, Patricia I. Oteiz. The Inhibitory Effect of ECG and EGCG Dimeric Procyanidins on Colorectal Cancer Cells’ Growth is Associated with Their Actions at Lipid Rafts and the Inhibition of the Epidermal Growth Factor Receptor Signaling |